MENU
KNSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kiniksa Pharmaceuticals International (KNSA) Ownership - Who owns Kiniksa Pharmaceuticals International?
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
2.16B
P/E Ratio
164.54
Total Cash
268.34M
Projected Growth
N/A
Total Debt
9.92M
Revenue
481.17M
Risk (Beta)
0.01
Dividend Yield
N/A
Total Cash/Share
3.68
Total Debt/Equity
N/A
Revenue/Share
6.61 USD as % of share price
Fundamentals
KNSA
Capitalization
2.16B
P/E Ratio
164.54
Risk (Beta)
0.01
Dividend Yield
N/A
Total Cash
268M
Total Cash/Share
3.68
Total Debt
9.92M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.61%
Revenue
481M
ROE
N/A
Book Value
457M
P/B Ratio
4.71
Cash Flow
N/A
Earnings
-0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
20K
Current Ratio
3.66
Current Revenue Per Employee
437412.70
Dividends Per Share - Security
N/A
EBITDA
-14.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
55.25
Revenue To Assets
-3.03
Shares Held By Institutions
1.09B
Shares Outstanding - Current
73M
Total Liabilities
142M
Total Volume MTD
N/A
Value
-1
Gain YTD
49.343
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com